Summary
A 31-year-old government contractor was denied a security clearance under Guideline H (Drug Involvement) due to his admitted marijuana use for medical purposes. The Statement of Reasons specifically cited his use of marijuana and his stated intention to continue using it, raising concerns under Disqualifying Conditions AG ¶ 25(a), AG ¶ 25(c), and AG ¶ 25(g).
The denial was based on several factors. The applicant admitted to using marijuana for medical reasons, which remains illegal under federal law. Furthermore, he expressed an intent to continue this use, despite acknowledging the conflict with federal statutes.
Crucially, the applicant failed to provide sufficient evidence of actions taken to mitigate his drug involvement. He did not establish a pattern of abstinence or demonstrate concrete steps to resolve the security concerns, ultimately leading to the denial of his security clearance.
Why the Applicant Was Denied
- The applicant admitted to using marijuana for medical purposes, which is illegal under federal law.
- He expressed an intent to continue using marijuana despite acknowledging the conflict with federal law.
- The applicant did not provide evidence of actions taken to mitigate his drug involvement or establish a pattern of abstinence.
Conditions Referenced
- AG ¶ 25(a)appliedIllegal Use of Controlled Substances
- AG ¶ 25(c)appliedIllegal Possession of a Controlled Substance
- AG ¶ 25(g)appliedExpressed Intent to Continue Drug Involvement
Key Rule Quoted
“The illegal use of controlled substances, to include the misuse of prescription drugs, and the use of other substances that can cause physical or mental impairment or are used in a manner inconsistent with their intended use can raise questions about an individual’s reliability and trustworthiness.”
Procedural Posture
- SOR issuedMar 11, 2024
- Answer filedApr 22, 2024
- Hearing heldOct 1, 2024Decision issued by Administrative Judge Jennifer I. Goldstein.
- Decision dateOct 1, 2024
Cite For
- Denial of Security Clearance Due to Drug Involvement Under Guideline H
- Importance of Compliance with Federal Law Regarding Controlled Substances
- Failure to Provide Mitigating Evidence in Drug-related Cases